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Oxidative stressAbstract Experimental autoimmune encephalomyelitis (EAE) is a well-established animal model
of multiple sclerosis. This study aimed to investigate the protective and therapeutic effects of Nigella
sativa (N. sativa) seeds (2.8 g/kg body weight) in EAE-induced rats. EAE-induced animals were
divided into: (1) EAE-induced animals (‘‘EAE’’ group). (2) ‘‘N. sativa+ EAE’’ group received a
daily oral administration of N. sativa 2 weeks prior to EAE induction until the end of the
experiment. (3) ‘‘EAE + N. sativa’’ group received a daily oral administration of N. sativa after
the appearance of the ﬁrst clinical signs until the end of the experiment. All animals were sacriﬁced
at the 28th day post EAE-induction. Disease pathogenesis was monitored using a daily clinical
scoring, body weight, open ﬁeld test, histopathological and ultrastructural examination and
determination of some oxidative stress parameters in the cortex and hippocampus. N. sativa
ameliorated the clinical signs and suppressed inﬂammation observed in EAE-induced rats. In
addition, N. sativa enhanced remyelination in the hippocampus. However, protection of rats with
N. sativa administered 2 weeks prior to EAE induction and its continuation until the end of therocess;
mmune
O, light
drocyte
d ﬁber;
; TCA,
elinated
Nigella sativa in encephalomyelitis-induced rats 183experiment resulted in a signiﬁcant increase in the cortical lipid peroxide level with reference to
control and ‘‘EAE’’ rats. In conclusion, N. sativa seeds could be used as a protective agent or an
adjunct treatment for EAE even when the treatment started after the appearance of the ﬁrst clinical
signs. However, the dose and duration of N. sativa must be taken into consideration to avoid its
probable pro-oxidant effect.
ª 2014 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. All rights
reserved.Introduction
Multiple sclerosis (MS) is an immune-mediated, demyelinating
neurodegenerative disease of the central nervous system (CNS)
of young adults with a female predominance (Compston and
Coles, 2002, 2008). It is a chronic progressive, potentially dis-
abling disorder with considerable social impact and economic
consequences (Sadovnick and Ebers, 1993). Experimental
autoimmune encephalomyelitis (EAE) is a well-established ani-
mal model of MS in which the immune system attacks the
myelin protein of the CNS and leads to inﬂammatory demye-
lination and oligodendrocyte loss (Frohman et al., 2006;
Compston and Coles. 2008; Moore, 2010).
Experimental autoimmune encephalomyelitis is induced in
laboratory animals by immunization with myelin-derived
antigens; and believed to be mediated by activation of
myelin-reactive CD4+ T cells. Expression of high levels of
proinﬂammatory cytokines and chemokines (small chemotac-
tic cytokines) in the brain is thought to contribute to the initi-
ation and maintenance of EAE (Godiska et al., 1995;
Ransohoff et al., 1996). Myelin oligodendrocyte glycoprotein
(MOG) is a strong encephalitogen, comprising less than
0.05% of all myelin proteins and located exclusively on the
surface of CNS myelin sheaths. MOG is a unique myelin auto-
antigen as it induces not only an encephalitogenic T-cell
response in susceptible species, but also a demyelinating auto-
antibody response (Gold et al., 2006).
Zamvil and Steinman (1990) reported that EAE develop-
ment is characterized by the inﬁltration of reactive leukocytes
into the CNS. Recruited reactive macrophages/microglia are
effector cells in EAE impairing oligodendrocyte axon function
(Raivich and Banati, 2004). Astrocytes are involved in multiple
and complex actions, including the regulation of the produc-
tion of pro- and anti-inﬂammatory cytokines (De Groot
et al., 1999; Ambrosini et al., 2002, 2005). In addition, a num-
ber of studies reported that reactive oxygen species (ROS) play
a key role in myelin damage, contributing to several of the pro-
cesses underlying MS pathogenesis (Miller et al., 2010; Van
Horssen et al., 2011).
The use of natural products as drugs has increased substan-
tially over the last decade to treat many pathological condi-
tions instead of the use of synthetic drugs because of their
safety, availability, and ease of administration. Nigella sativa
(N. sativa), also known as black seed or black cumin, belongs
to the family of the Ranunculaceae and it is native to Mediter-
ranean countries. Many beneﬁcial biological properties of N.
sativa extracts have been reported such as anti-inﬂammatory
(Houghton et al., 1995; Alemi et al., 2013; Pichette et al.,
2012), antioxidative (Burits and Bucar, 2000) and neuroprotec-
tive (Kanter et al., 2006). In addition, N. sativa has been widely
used in neurodegenerative diseases like Parkinson andAlzheimer because of its antioxidant potential (Hajra, 2011).
Therefore, the aim of the present study was to investigate the
protective and therapeutic effects of N. sativa in the cortex
and the hippocampus of EAE-induced female Wistar rats.Methods
Experimental animals, induction of EAE and clinical scoring
Adult femaleWistar rats (age between 6 and 8 weeks) were used
in this experiment. They were maintained under ﬁxed appropri-
ate conditions of housing and handling and were given food and
water ad libitum. All animals received humane care in compli-
ancewith the guidelines of the Ethics Committee of theNational
Research Center, Egypt that followed the recommendations of
the National Institutes of Health Guide for Care and Use of
Laboratory Animals (Publication Nos. 85–23, revised 1985).
The EAE was induced according to Adelmann et al. (1995)
with some modiﬁcations. Under light Halothane anesthesia,
EAE was induced by a single subcutaneous injection in the tail
base with an emulsion of 100 lg MOG35–55 dissolved in 100 ll
phosphate buffered saline (PBS), mixed with 100 ll complete
Freund’s adjuvant (CFA) containing 1 mg/ml of Mycobacte-
rium tuberculosis.
For the evaluation of the disease course, all rats were
weighed and examined daily from the sensitization until the
28th day after immunization. An adapted EAE scoring scale
was used (Al-Izki et al., 2012). Animals were scored 0 = nor-
mal. 0.5 = incomplete ﬂaccid tail. 1 = fully ﬂaccid tail.
1.5 = semi-impaired righting reﬂex. 2 = impaired righting
reﬂex. 2.5 = weakness of hind limb. 3 = hind limb paresis.
4 = complete hind limb paralysis. 5 = moribund/death. Con-
trol rats were handled in the same manner as the rats of other
EAE-induced groups to affront the same degree of stress.
Chemicals
Rat synthetic myelin oligodendrocyte glycoprotein peptide35–55
(MOG35–55) was purchased from Titan Biotech Limited,
Bhiwadi, India. Phosphate buffered saline (PBS) was obtained
from the Bio Basic Inc., USA. Complete Freund’s adjuvant
(CFA), Thiobarbituric acid (TBA) and reduced glutathione
were purchased from Sigma Aldrich, Germany. 1-Chloro-
2,4-dinitrobenzene (CDNB) was purchased from Sigma
Aldrich, St. Louis, USA. Trichloroacetic acid (TCA) was
obtained from SDFCL (SD Fine-Chem Limited), Egypt.
Potassium phosphate buffer pH 7.4 (50 mM/L, Triton · 0.1%,
EDTA 0.5 ml), potassium phosphate buffer pH 6.5 (100 mM/
L) and kits for the determination of oxidative stress parame-
ters were obtained from Bio Diagnostic Co., Giza, Egypt.
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International Medical Centre) pharmaceuticals Co., Egypt.
N. sativa seeds
Syrian N. sativa seeds were purchased from a local market in
Cairo, Egypt. Grinded whole N. sativa seeds were suspended
in distilled water and given orally to rats (2.8 g/kg body
weight) by means of a gastric tube. The LD50 of N. sativa oil
in rats is 28.8 ml/kg (Zaoui et al., 2002). The dose of N. sativa
seeds used in this study was calculated as 1/10 of LD50 of its
oil, to be completely safe.
Experimental design
Animals immunized with MOG were divided into 3 groups: (1)
EAE-induced animals (‘‘EAE’’ group) received a daily oral
administration of distilled water until the end of the experi-
ment. (2) The animals of the second group (‘‘N. sati-
va+EAE’’ group) received a daily oral administration of N.
sativa 2 weeks prior to EAE induction until the end of the
experiment. (3) The animals of the third group (‘‘EAE + N.
sativa’’ group) received a daily oral administration of N. sativa
after the appearance of the ﬁrst clinical signs until the end of
the experiment. All animals were sacriﬁced by sudden decapi-
tation at the 28th day post immunization. Control animals
received a single subcutaneous injection of 200 ll PBS in the
tail base and then received daily oral injections of distilled
water until the end of the experiment. They were sacriﬁced
simultaneously with the treated groups.
Open ﬁeld (OF) test
The apparatus was a square 66 · 66 cm with surrounding walls
of 30 cm height. The base of the OF was divided into 36
squares. The central zone represented 25% of the total arena.
The duration of the test was set to be ten min. The OF param-
eters measured were the number of squares crossed, the time
spent in the central zone, the number of rears, the number of
grooming, the number of fecal boli and the number of urine
patches. The OF test was done once on the 20th day post
immunization.
Histopathological assessment
After decapitation, brains were ﬁxed in buffered neutral 10%
formalin, embedded in parafﬁn and sectioned at 8 micrometer
thickness. The brain sections were stained with hematoxylin
and eosin (H&E) according to Banchroft et al. (1996). Slides
were then examined through the light microscope (Zeiss, Ger-
many) to investigate the deep cerebral cortex and white matter
and hippocampus.
Transmission electron microscopy (TEM) for brain tissues
Brains from different experimental groups were dissected to
obtain the cortex and hippocampus and then were ﬁxed with
1% glutaraldehyde and 1.5% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.2, at 4 C. The samples were then
washed with PBS followed by washing in 0.1 M cacodylatebuffer, pH 7.2, and post-ﬁxed in 1% osmium tetroxide in
0.1 M cacodylate buffer for 1.5 h at room temperature. The
samples were then washed brieﬂy in deionized water, dehy-
drated by a graded ethanol series; inﬁltrated using propylene
oxide and EPON epoxy resin and ﬁnally embedded in epoxy
resin. The samples that had been mixed with epoxy resin were
loaded into capsules and polymerized at 60 C for 24 h. Thin
sections were cut using a RMC MT-X ultramicrotome and
collected on copper grids. Images were collected using a JEOL
transmission electron microscope JEM 1400 (Joel, LTD,
Tokyo, Japan) operating at 80 kV.
Biochemical analysis
Tissue homogenization
After decapitation, the brains were transferred rapidly to an
ice-cold Petri dish. Each brain was dissected to remove the
cortex and hippocampus. The brain samples were weighed
and kept at 58 C until analyzed. Each brain sample was
then homogenized in 5% w/v 50 mM phosphate buffer, pH
7.6. The homogenates were centrifuged at 8000 rpm
(·g= 7012) for 15 min. The supernatants were stored at
58 C until use.
Determination of lipid peroxidation
Lipid peroxidation was assayed by measuring the levels of mal-
ondialdehyde (MDA) in the brain tissues. MDA was deter-
mined by measuring thiobarbituric reactive species using the
method of Ruiz-Larrea et al. (1994) in which the thiobarbituric
acid reactive substances react with thiobarbituric acid to pro-
duce a pink colored complex whose absorbance is read at
532 nm in a Helios Alpha Thermospectronic (UVA 111615,
England).
Determination of reduced glutathione (GSH) levels
The assay of reduced glutathione (GSH) levels was performed
using Biodiagnostic Kit No. GR 25 11, which is based on the
spectrophotometric method of Beutler et al. (1963). It depends
on the reduction of 5,50-dithiobis-2-nitrobenzoic acid (DTNB)
with glutathione to produce yellow color the absorbance of
which is measured at 405 nm in a Helios Alpha Thermospec-
tronic (UVA 111615, England).
Determination of nitric oxide (NO) levels
The assay of nitric oxide (NO) was carried out using Biodiag-
nostic Kit No. NO 25 33. This method is based on the spectro-
photometric method of Montgomery and Dymock (1961)
which depends on the measurement of endogenous nitrite con-
centration as an indicator of nitric oxide production. The
resulting azo dye has a bright reddish–purple color whose
absorbance is read at 540 nm in a Helios Alpha Thermospec-
tronic (UVA 111615, England).
Determination of catalase activity
Catalase activity was measured using Biodiagnostic Kit No.
CA 25 17 which is based on the spectrophotometric method
described by Aebi (1984). Catalase reacts with a known quan-
tity of hydrogen peroxide and the reaction is stopped after
1 min with catalase inhibitor. In the presence of peroxidase,
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hydroxybenzene sulfonic acid (DHBS) and 4-aminophenazone
to form a chromophore with color intensity inversely propor-
tional to the activity of catalase in the sample. The absorbance
of chromophore color is read at 510 nm in a Helios Alpha
Thermospectronic (UVA 111615, England).
Determination of glutathione-S-transferase (GST) activity
Glutathione-S-transferase (GST) activity was determined
according to the method of Habig et al. (1974). 0.4 ml potas-
sium phosphate buffer (50 mmol/l; pH 6.5), 0.1 ml of supernatant,
1.2 ml water and 0.1 ml CDNB (1-chloro-2,4-dinitrobenzene,
30 mmol/l) were added and incubated in a water bath at
37 C for 10 min. After incubation, 0.1 ml of reduced glutathi-
one (30 mmol/l) was added. The change in absorbance was
measured at 340 nm at one min interval.
Statistical analysis
The maximum clinical score, the days of relapse and the days
of remission were assessed using non-parametric statistics,
Kruskal–Wallis test followed by Mann–Whitney U statistics
(P< 0.05 was considered signiﬁcant). Data of body weights,
open ﬁeld and oxidative stress parameters were analyzed by
analysis of variance (ANOVA) followed by Duncan’s post
hoc test when the F-test was signiﬁcant (p< 0.05). All analyses
were performed using SPSS software (version 16.0) for
windows.Fig. 1 Effect of EAE induction by MOG and its treatment with N.
Values represent mean ± S.E.M.
Table 1 Summary of clinical data obtained from the EAE induced
Groups Number of rats
in each group
‘‘EAE’’ 12
‘‘EAE+ N. sativa’’ 11
‘‘N. sativa + EAE’’ 9Results
Effect of EAE induction by MOG and its treatment with
N. sativa on the daily clinical scores in Wistar rats
As shown in Fig. 1 and Tables 1 and 2, relapse and remission
episodes alternated, suggesting a relapsing-remitting EAE
model. N. sativa administration after the disease onset attenu-
ated the severity of the clinical signs from 13th day post immu-
nization and until the end of the experiment. Meanwhile, N.
sativa in the ‘‘N. sativa+EAE’’ group greatly prevented the
clinical signs during the whole course of the experiment com-
pared to the ‘‘EAE’’ group. The ‘‘N. sativa+ EAE’’ group
showed a signiﬁcant decrease in the days of relapses with
respect to the ‘‘EAE + N. sativa’’ and ‘‘EAE’’ groups.
The cumulative clinical score/rat (sum of scores measured
from disease onset/rat, as an index of disease severity) for
the EAE-induced groups is demonstrated in Fig. 2. The ‘‘N.
sativa+ EAE’’ group showed a signiﬁcant decrease in the
cumulative score/rat with respect to both the ‘‘EAE’’ and
‘‘EAE + N. sativa’’ groups.
Effect of EAE induction by MOG and its treatment with N.
sativa on the body weight of EAE in adult female Wistar rats
As shown in Fig. 3, the ‘‘EAE’’ group showed a general
decrease in body weight from 4th day post immunization until
the end of the experiment. ‘‘N. sativa + EAE’’ group showed asativa (2.8 g/kg body) on the daily clinical scores in Wistar rats.
group and N. sativa (2.8 g/kg) treated and protected groups.
Incidence of
EAE signs
% of rats recovered from
EAE signs until decapitation
11/12 (91.67%) 5/11 (45.45%)
10/11 (91.00%) 10/10 (100.00%)
8/9 (88.89%) 7/8 (87.50%)
Fig. 2 Cumulative clinical score for each rat in the ‘‘EAE’’,
‘‘EAE + N. sativa’’ and ‘‘N. sativa + EAE’’ groups. Values repre-
sent mean ± S.E.M. A and B: different letters mean signiﬁcant
changes. Signiﬁcance was tested using the Mann–Whitney U-test.
Fig. 3 Effect of EAE induction by MOG and its treatment with N.
Values represent mean ± S.E.M.
Table 2 Effect of a daily oral administration of N. sativa (2.8 g/kg) on the days of relapse and remission in EAE induced adult female
Wistar rats.
Experimental groups Number of animals
in each group
Days of relapse Days of remission
Mean rank Mann–Whitney U Signiﬁcance Mean rank Mann–Whitney U Signiﬁcance
‘‘EAE’’ 11 11.77 46.50 n.s. 10.23 46.50 n.s.
‘‘EAE+ N. sativa’’ 10 10.15 11.85
‘‘EAE’’ 11 12.41 17.50 * 7.73 19.00 *
‘‘N. sativa+EAE’’ 8 6.69 13.12
‘‘EAE+ N. sativa’’ 10 12.15 13.50 * 6.90 14.00 *
‘‘N. sativa+EAE’’ 8 6.19 12.75
n.s.: non-signiﬁcant.
* p< 0.05 signiﬁcant.
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trol group from 11th to 20th day post immunization. However,
treatment of EAE-induced rats with N. sativa seeds
(‘‘EAE + N. sativa’’) failed to restore the recorded signiﬁcant
decrease of body weight in sick rats to control values.
Effect of EAE induction by MOG and its treatment with
N. sativa on open ﬁeld parameters recorded from adult female
Wistar rats
From Table 3 it can be noticed that the rats of the ‘‘EAE’’
group, signiﬁcantly, spent more time in the center than those
of the other groups. The number of rears was signiﬁcantly
increased in the ‘‘N. sativa + EAE’’ group with reference to
other tested groups.
Effect of EAE induction by MOG and its treatment with
N. sativa on the histopathological ﬁndings in Wistar rats
Perivascular mononuclear cell aggregation was observed in the
deep cerebral gray matter, lesions including glial cell prolifera-
tion in the deep gray matter associated with neuronal degener-
ation and necrosis among variable numbers of motor neurons
(Fig. 4c), while lesions in the white matter, including diffusesativa (2.8 g/kg) on the body weight of adult female Wistar rats.
Table 3 Effect of EAE induction by MOG and its treatment with N. sativa (2.8 g/kg) on some open ﬁeld parameters recorded from
adult female Wistar rats.
Parameters measured Control group ‘‘EAE’’ group % D ‘‘EAE+
N. sativa’’ group
% D ‘‘N. sativa+
EAE’’ group
% D F-test
Number of squares
crossed
161.67 ± 9.34 (6) 146.50 ± 8.50 (6) 9.38 158.83 ± 13.41 (6) 1.76 141.17 ± 6.37 (6) 12.68 n.s.
Number of rears 22.00 ± 2.11 (6) A 24.67 ± 1.58 (9) A 12.14 23.83 ± 1.58 (6) A 8.32 30.00 ± 1.13 (6) B 36.36 *
Time spent in center
in seconds
11.17 ± 0.87 (6) A 17.57 ± 2.36 (7) B 57.30 7.57 ± 0.72 (7) A 32.23 7.50 ± 1.15 (6) A 32.86 *
Number of grooming 10.36 ± 1.22 (8) AB 7.42 ± 0.74 (11) A 30.70 11.44 ± 1.18 (6) B 7.62 8.71 ± 1.43 (7) AB 18.06 *
Number of fecal boli 3.38 ± 1.13 (8) 5.75 ± 0.80 (8) 70.12 3.44 ± 0.78 (9) 1.78 4.86 ± 0.88 (7) 43.79 n.s.
Number of urine
patches
1.40 ± 0.43 (10) 1.25 ± 0.41 (11) 10.71 2.11 ± 0.48 (9) 50.71 1.22 ± 0.36 (8) 12.86 n.s.
Values represent mean ± S.E.M.
Number of animals is shown between parentheses.
% D: percentage difference with reference to control values.
n.s.: non-signiﬁcant.
A and B: different letters mean signiﬁcant changes.
* p < 0.05 signiﬁcant.
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observed in Fig. 4d. The extent of glial cell proliferation and
neuronal damage was reduced in the ‘‘EAE + N. sativa’’
group and markedly ameliorated in the ‘‘N. sativa + EAE’’
group (Fig. 4 e and h).
Extensive neuronal necrosis comprising the Cornu Ammo-
nis 3 (CA3) (Fig. 5e–h) and vacuolation of granular cells were
observed in the Dentate gyrus (DG) region in the ‘‘EAE’’
group compared with the ‘‘EAE + N. sativa’’ and ‘‘N. sati-
va + EAE’’ groups that showed normal histological structure
of granular cells (Fig. 5i–l).
Effect of EAE induction by MOG and its treatment with
N. sativa on the ultrastructure of myelin sheath using
transmission electron microscopy (TEM) in Wistar rats
The ultrastructural examination of the ‘‘EAE’’ group revealed
slight demyelination of the cerebral cortex and partial to com-
plete demyelination of the hippocampus (Figs. 6 and 7). TEM
micrographs of the brain areas of the ‘‘EAE + N. sativa’’
group showed slight demyelination of the cerebral cortex, par-
tial incomplete and complete remyelination of most nerve
ﬁbers of the hippocampus. Meanwhile, micrographs of the
‘‘N. sativa + EAE’’ group showed normal myelin sheath struc-
ture of the cerebral cortex. In addition, most of the myelinated
ﬁbers were in a state of remyelination in the hippocampus.
Effect of EAE induction by MOG and its treatment with
N. sativa on some oxidative stress parameters in different brain
areas of Wistar rats
As shown in Table 4, cortical MDA levels showed non-signif-
icant changes between the control, ‘‘EAE’’ and ‘‘EAE + N.
sativa’’ groups. However, a signiﬁcant increase was recorded
in the cortical MDA level of the ‘‘N. sativa+ EAE’’ group
in comparison to both control and ‘‘EAE’’ groups. Cortical
GSH levels revealed signiﬁcant increases in both ‘‘EAE’’ and
‘‘EAE + N. sativa’’ groups relative to control value. Mean-
while, a signiﬁcant decrease was observed in the GSH level
in the ‘‘N. sativa+ EAE’’ group in comparison to the control,
‘‘EAE’’ and ‘‘EAE + N. sativa’’ groups. Variations in corticalNO levels demonstrated signiﬁcant decreases in both ‘‘EAE’’
and ‘‘EAE + N. sativa’’ groups with respect to control levels.
However, a signiﬁcant increase in NO level was recorded in the
‘‘N. sativa+EAE’’ group in comparison to other experimen-
tal groups. Catalase activity in the cortex of the ‘‘EAE + N.
sativa’’ group showed a signiﬁcant decrease relative to other
experimental groups. The cortical GST activity recorded sig-
niﬁcant decreases among the experimental groups except for
a non-signiﬁcant change between the ‘‘EAE’’ and ‘‘EAE + N.
sativa’’ groups.
Variations in the oxidative stress parameters in the hippo-
campus are presented in Table 5. The hippocampal MDA lev-
els recorded signiﬁcant decreases among the experimental
groups except for a non-signiﬁcant change between the control
and ‘‘EAE’’ groups. A signiﬁcant increase in NO level in the
‘‘EAE + N. sativa’’ group with respect to the control and
‘‘N. sativa+ EAE’’ groups was also observed. In addition, a
signiﬁcant decrease in catalase activity in the ‘‘EAE + N. sati-
va’’ group with respect to the control, ‘‘EAE’’ and ‘‘N. sati-
va+EAE’’ groups was detected.Discussion
It has been reported that active induction in which animals
were given a CNS antigen results in the initiation of an
immune response within the CNS, which leads to either a mon-
ophasic EAE, relapsing-remitting (RR) EAE or a chronic EAE
depending on the antigen and the species or strain of animal
used (Baker et al., 2011; Batoulis et al., 2011; Denic et al.,
2011; ‘t Hart et al., 2011). In the present study, rats of
the ‘‘EAE’’ group showed alternative periods of relapses
and remissions, suggesting a relapsing remitting (RR) EAE
model.
Protective treatment with N. sativa showed a signiﬁcant
reduction in the number of days of relapses with respect to
the ‘‘EAE + N. sativa’’ group. Moreover, the ‘‘N. sati-
va + EAE’’ group showed a signiﬁcant decrease in the cumu-
lative score/rat with respect to both the ‘‘EAE’’ and
‘‘EAE + N. sativa’’ groups. Thus, it could be suggested that
N. sativa ameliorates the ‘‘clinical’’ manifestations of EAE
Fig. 4 Cerebrum deep gray matter and white matter (H & E ·400). (a) Control group showing normal stained motor neurons in the deep
cerebral gray matter that are surrounded by glial cells. (b) Control group showing small blood vessel with normal clear Virchow Robin
space. (c) ‘‘EAE’’ group showing extensive glial cell proliferation associated with necrosis and shrinkage of motor neurons (arrow). (d)
‘‘EAE’’ group showing perivascular lymphocytic aggregation with extensive glial cell proliferation in the cerebral white matter. (e)
‘‘EAE + N. sativa’’ group showing mild glial cell proliferation in cerebral gray matter with single neuronal damage. (f) ‘‘EAE + N.
sativa’’ group showing glial cell proliferation in the cerebral white matter with normal empty Virchow Robin space. (g) ‘‘N.
sativa+EAE’’ group showing normal motor neuronal structure and normal glial cell distribution. (h) ‘‘N. sativa+ EAE’’ group showing
mild glial cell proliferation in the cerebral white matter.
188 H.M. Fahmy et al.and decreases the severity of the disease, especially in the pro-
tected ‘‘N. sativa+ EAE’’ group.
Experimental autoimmune encephalomyelitis is accompa-
nied by an impressive loss of body weight (Encinas et al.,
2001). Weight loss in EAE is most likely due to side effects
of inﬂammatory mediators (Strassmann et al., 1992). Al-Izki
et al. (2012) suggested that losing weight indicates active dis-
ease and gaining weight indicates recovery. The observed sig-
niﬁcant decrease in body weights in the ‘‘EAE’’ group is in
line with the results of Pollak et al. (2000) and may indicate
active disease and could arise from anorexia (Wekerle and
Kurschus, 2006), suppression of appetite or decreasing ability
to adequate ﬂuid intake (Encinas et al., 2001).
Traditionally, a tincture prepared from N. sativa seeds has
been shown to be useful in the cases of loss of appetite(Sharma et al., 2009). In addition, it has been reported that the
supplements ofmedicinal plantmixture includingN. sativa seeds
improved the daily body weight gain for different farm animals
(El-Gaafarawy et al., 2003; Hassan, 2009). In parallel with these
reports, pre-treatment of rats, in the present study,withN. sativa
seeds 2 weeks prior to immunization and continuation ofN. sati-
va administration till 28th day post immunization succeeded in
restoring the body weight of sick animals to control values from
7th to 10th day besides the 21th day post immunization. More-
over, the ‘‘N. sativa + EAE’’ group showed signiﬁcant increase
in body weight in comparison to the control group from 11th to
20th day post immunization. The failure in restoring control
body weight in the ‘‘EAE + N. sativa’’ groupmay be attributed
to the short period of administration of N. sativa seeds in com-
parison to the ‘‘N. sativa+ EAE’’ group.
Fig. 5 Hippocampus (H&E ·400). Cornu Ammonis (CA1) (a) Control group showing normal thickness of small pyramidal cells that
have vesicular nuclei. (b) ‘‘EAE’’ group showing a decrease in the thickness of small pyramidal cell layer with loss of neurons associated
with proliferation of capillary endothelium. (c) ‘‘EAE + N. sativa’’ group showing a focal reduction in the small pyramidal cell layer
thickness with focal loss neurons. (d) ‘‘N. sativa + EAE’’ group showing maintaining of the normal thickness of small pyramidal cell.
CA3. (e) Control group showing aggregation of large pyramidal cell with vesicular nuclei. (f) ‘‘EAE’’ group showing extensive necrosis of
large pyramidal cells with shrinkage of the cytoplasm and deep basophilic pyknotic nuclei (arrow). (g) ‘‘EAE + N. sativa’’ group showing
individual necrosis of large pyramidal cell (arrow). (h) ‘‘N. sativa+ EAE’’ group showing individual necrosis of large pyramidal cell.
Dentate gyrus (DG). (i) Control group showing compact aggregation of small granular cells and molecular layer that contained pyramidal
and glial cells. (j) ‘‘EAE’’ group showing vacuolation and extensive loss of granular cell associated with neuronal necrosis, neuronophagia
(arrow) and glial cell proliferation in the molecular layer. (k) ‘‘EAE + N. sativa’’ group showing necrosis of individual neurons (arrow)
with glial cell proliferation. (l) ‘‘N. sativa+ EAE’’ group showing mild glial cell proliferation of the molecular layer associated with
necrosis of individual neurons (arrow).
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anxiety, and locomotor behavior (Frye and Rhodes, 2008). The
number of central square entries and the duration of time spent
in the central square are measures of exploratory behavior and
anxiety. A high frequency/duration of these behaviors indicates
the high exploratory behavior and low anxiety levels (Walsh and
Cummins, 1976). In the present work, rats of the ‘‘EAE’’ group
spent signiﬁcantlymore time in the center compared to the other
tested groups. It may be suggested that the rats of the ‘‘EAE’’
group showed higher exploratory and lower anxiety behavior
levels besides less emotion with respect to other groups, which
is inconsistent with the ﬁndings of the previous studies (Peruga
et al., 2011; Rodrigues et al., 2011).
The number of line crosses and the frequency of rearing in
OFT are usually used as measures of locomotor activity, butare also measures of exploration and anxiety. A high frequency
of these behaviors indicates increased locomotion and explora-
tion and/or a lower level of anxiety (Walsh and Cummins,
1976). In the present OFT, rats of the ‘‘N. sativa+ EAE’’
group showed a signiﬁcant increase in the number of rears with
respect to other experimental group. It could be suggested that
N. sativa when given 2 weeks prior to EAE induction increased
the locomotor activity as well as the exploration and decreased
the anxiety of rats. These results are in line with the signiﬁcant
amelioration of the clinical signs detected in the ‘‘N. sati-
va+EAE’’ group. Moreover, a previous study showed that
N. sativa seed constituents (aqueous extract, ﬁxed oil, volatile
oil, and major constituents of the volatile oil) produced anti-
anxiety effect in different tests used as models for exploration
of induced anxiety (Raza et al., 2006).
Fig. 6 TEM micrographs of the cortex. (A) Control group, (B) ‘‘EAE’’ group, (C) ‘‘EAE + N. sativa’’ group and (D) ‘‘N.
sativa+EAE’’ group. M, myelinated ﬁber; U, unmyelinated ﬁber; PD, partially demyelinated ﬁber; R, remyelinated ﬁber; MO, medium
oligodendrocyte process; DO, dark oligodendrocyte process; LA, light astrocyte process; DA, dark astrocyte process.
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OFT, it could be suggested that the number of rears is the pref-
erable OFT parameter to test the EAE induced behavior
changes in Wistar rats rather than the time spent in the center.
The present histopathological examination of the rats
belonging to the ‘‘EAE’’ group revealed the appearance of per-
ivascular mononuclear cell aggregation in the deep cerebral
cortex and white matter, which is in agreement with previous
study of Zamvil and Steinman (1990).
Autoimmune encephalomyelitis has originally been
believed to be a ‘‘white matter disease.’’ However, some
reports suggest additional pathologic changes in the gray mat-
ter, including loss and/or atrophy of motor neurons also exist
(Derfuss et al., 2009; Rudick and Trapp, 2009). These reported
alterations in the gray matter of MS patients were evidenced in
the present histopathological examination of the brain of rats
belonging to the ‘‘EAE’’ group in which perivascular mononu-
clear cell aggregation and lesions including glial cell prolifera-
tion associated with neuronal degeneration and necrosis
among variable numbers of motor neurons were seen in the
deep cerebral cortex.
Demyelination in EAE as in MS is a result of inﬂammatory
lesions in the white matter responsible for clinical deﬁcits
(Trapp et al., 1999). In the present study, the ultrastructural
examination of brain areas of rats of the ‘‘EAE’’ group
revealed slight demyelination of the cerebral cortex in addition
to partial to complete demyelination of the hippocampus.
From the present clinical signs, histopathological ﬁndings
and ultrastructural examination of rats belonging to the
‘‘EAE’’ group, it could be concluded that a single subcutane-
ous immunization of Wistar rat with 100 lg MOG in CFA
containing 1 mg/ml of M. tuberculosis at the base of the tail
could provide a successful EAE animal model for MS thatfulﬁlls the majority of histopathological characteristics of the
well-established EAE models.
A key principle of traditional Chinese medicine is that mul-
tiple ingredients in a plant extract are more effective and less
toxic than a single puriﬁed active ingredient or a puriﬁed drug
derived from a plant product (Wong et al., 2010). Based on this
concept, the whole N. sativa seed was the choice in this study
to be less toxic, easy to administrate and more effective than its
single puriﬁed active ingredients.
It has been reported that inﬂammatory cytokines and medi-
ators are key components in the inﬂammatory process
(Germano et al., 2008). N. sativa seeds were used as anti-
inﬂammatory (Houghton et al., 1995; Mutabagani and El-
Mahdy, 1997) agent. Several studies revealed that N. sativa
seed oil contains potent, but non-toxic compounds that sup-
press excessive inﬂammatory molecules (Shahzad et al., 2009;
Butt and Sultan, 2010).
In the present investigation, the extent of glial cell prolifer-
ation and neuronal damage in the deep cerebral cortex was
reduced in the ‘‘EAE+ N. sativa’’ group and markedly ame-
liorated in the ‘‘N. sativa+ EAE’’ group as compared to the
‘‘EAE’’ group. Regarding the hippocampus, the ‘‘EAE + N.
sativa’’ and ‘‘N. sativa+EAE’’ groups showed normal histo-
logical structure of granular cells.
Thymoquinone (TQ), most active ingredient in N. sativa,
has been proved experimentally to be an anti-inﬂammatory
substance (Chehl et al., 2009). It signiﬁcantly reduced the levels
of pro-inﬂammatory mediators {IL-1b, IL-6, TNF-a, IFN-c
and PGE (2)} and increased level of IL-10 in arthritic rats
(Umar et al., 2012). Moreover, Mohamed et al. (2005) found
that encephalomyelitis could be prevented and ameliorated
by TQ treatment. Therefore, the protective and the ameliora-
tive effects of N. sativa administration to EAE-induced rats,
Fig. 7 TEM micrographs of the hippocampus. (A) Control group, (B) ‘‘EAE group’’, (C) ‘‘EAE + N. sativa’’ group and (D) ‘‘N.
sativa+ EAE’’ group. M, myelinated ﬁber; U, unmyelinated ﬁber; DF, demyelinated ﬁber; R, remyelinated ﬁber; LO, light
oligodendrocyte process; MO, medium oligodendrocyte process; DO, dark oligodendrocyte process; LA, light astrocyte process; DA: dark
astrocyte process.
Table 4 Effect of EAE induction by MOG and its treatment with N. sativa (2.8 g/kg) on the levels of MDA, GSH and NO and
activities of catalase and GST in the cortex of adult female Wistar rats.
Oxidative stress parameter Control group ‘‘EAE’’ group ‘‘EAE+ N.sativa’’ group ‘‘N.sativa + EAE’’ group F-test
Value % D Value % D Value % D
MDA (nmol/g tissue) 2.90 ± 0.26 (6) A 2.33 ± 0.26 (6) A 19.66 3.61 ± 0.30 (7) AB 24.48 5.11 ± 0.70 (8) B 76.21 *
GSH (mmol/g tissue) 3.60 ± 0.34 (6) A 5.30 ± 0.19 (8) B 47.20 5.11 ± 0.46 (8) B 41.94 1.59 ± 0.16 (6) C 55.83 *
NO (lmol/g tissue) 0.41 ± 0.04 (6) A 0.25 ± 0.03 (6) B 39.02 0.23 ± 0.02 (7) B 43.90 0.99 ± 0.08 (6) C 141.50 *
Catalase (U/g tissue) 13.99 ± 0.91 (5) A 14.01 ± 0.61 (5) A 0.14 7.96 ± 0.79 (6) B 43.10 13.96 ± 0.95 (6) A 0.21 *
GST (U/g tissue) 7.47 ± 0.11 (5) A 5.31 ± 0.33 (6) B 28.92 5.77 ± 0.53 (8) B 22.76 4.12 ± 0.34 (7) C 44.85 *
Values represent mean ± S.E.M.
Number of animals is shown between parentheses.
% D: percentage difference in comparison to control group.
A, B and C different letters mean signiﬁcant changes.
* p< 0.05 signiﬁcant.
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through the suppressive effect of its components on the inﬂam-
matory cytokines and mediators which are the key components
in the inﬂammatory processes (Germano et al., 2008).In the present investigation, partial to complete remyelina-
tion in the N. sativa treated and protected groups were clearly
detected by the ultrastructural examination of the brain areas
under investigation.
Table 5 Effect of EAE induction by MOG and its treatment with N. sativa (2.8 g/kg) on the levels of MDA, GSH and NO and
activities of catalase and GST in the hippocampus of adult female Wistar rats.
Oxidative stress parameter Control group ‘‘EAE’’ group ‘‘EAE+ N. sativa’’ group ‘‘N. sativa + EAE’’ group F-test
Value % D Value % D Value % D
MDA (nmol/g tissue) 19.51 ± 0.66 (6) A 21.00 ± 1.17 (6) A 7.63 15.69 ± 1.41 (5) B 19.58 8.47 ± 1.27 (5) C 56.59 *
GSH (mmol/g tissue) 5.78 ± 0.78 (6) 5.14 ± 0.69 (6) 11.07 4.26 ± 0.43 (6) 26.30 6.62 ± 0.49 (6) 14.53 n.s.
NO (lmol/g tissue) 0.39 ± 0.03 (6) A 0.48 ± 0.03 (7) AB 23.08 0.58 ± 0.03 (6) B 48.72 0.45 ± 0.06 (6) A 15.38 *
Catalase (U/g tissue) 6.74 ± 0.36 (6) A 6.36 ± 0.26 (7) A 5.64 3.53 ± 0.69 (6) B 47.63 6.62 ± 0.65 (5) A 1.78 *
GST (U/g tissue) 9.10 ± 0.40 (6) 9.14 ± 0.77 (7) 0.44 9.42 ± 0.96 (6) 3.52 8.30 ± 0.41 (5) 8.79 n.s.
Values represent mean ± S.E.M.
Number of animals is shown between parentheses.
% D: percentage difference in comparison to control group.
n.s.: non-signiﬁcant.
A, B and C: different letters mean signiﬁcant changes.
* p< 0.05 signiﬁcant.
192 H.M. Fahmy et al.It has been suggested that the inactivation of microglia
inhibits EAE (Heppner et al., 2005). Previously, it had been
reported that reactive microglia/macrophage contribute to
demyelination in EAE by killing oligodendrocyte with the
release of TNF-a (Zajicek et al., 1992). In addition, the
events that occur around the lesion site include the prolifer-
ation of astrocytes, which leads to astrocytic hypertrophy
and the expression of inhibitory molecules (Silver and
Miller, 2004).
As seen in the pathological examination, in the present
study, N. sativa administration resulted in a decreased number
of reactive astrocytes and proliferated microglial cells in the
EAE-induced rats. In support of the present role of N. sativa,
Bano et al. (2009) suggested that N. sativa is useful as a poten-
tial treatment for neurodegeneration after chronic toluene
exposure in rats. Hence, it could be suggested that the detected
remyelinating power of N. sativa in the EAE-induced rats
might be due to its inhibitory effect on astrocytic and microg-
lial proliferation.
Several studies reported that the elimination of macro-
phages or microglia suppresses clinical and histopathological
manifestations in rodent models of MS (Bauer et al., 1995;
Polﬂiet et al., 2002; Heppner et al., 2005). Therefore, the ame-
lioration in clinical symptoms, in the present study, in the N.
sativa treated groups could be attributed to the suppression
of inﬂammatory cells.
It is well known that the CNS is equipped with an endoge-
nous antioxidant defense mechanism consisting of antioxidant
enzymes. Production of these cytoprotective enzymes is
induced upon exposure to ROS via a mechanism regulated
at the transcriptional level (Itoh et al., 2003, 2004;
Motohashi and Yamamoto, 2004).
Reduced glutathione is the major thiol present in the brain
tissue, and the most important redox buffer in cells, which has
an important role in the protection against oxidative injury
due to ROS (Wang and Ballatori, 1998). Therefore, the present
signiﬁcant increases in GSH contents in the cerebral cortex of
the ‘‘EAE’’ group were expected in view of the increased pro-
duction of ROS. Unfortunately, these signiﬁcant increases in
cortical GSH persisted after the treatment of EAE-induced
rats with N. sativa and reversed to signiﬁcant decreases in
the protected group.Zheng and Bizzozero (2010) measured the levels of GSH
and lipid peroxidation products in the cerebellum during the
acute and chronic phases of MOG-induced EAE in C57BL/6
mice. They found that GSH levels were reduced in both acute
and chronic phases of EAE and the amount of lipid peroxida-
tion products was similar to that in controls both at the peak
of the disease and in the chronic phase. Moreover, in a recent
study of Dasgupta et al. (2013), the authors measured the lev-
els of GSH and lipid peroxide in the spinal cord regions during
the course of MOG35-55 peptide-induced EAE in C57BL/6
mice. The results showed that GSH levels were reduced during
acute EAE and returned to normal values in the chronic EAE
while the amount of lipid peroxidation products was high in
acute EAE and decreased to nearly normal levels in the
chronic phase.
The present data of the ‘‘EAE’’ group revealed non-signif-
icant changes in MDA levels in the cortex and hippocampus,
which is in agreement with the results of Zheng and
Bizzozero (2010) and Dasgupta et al. (2013). In addition,
non-signiﬁcant changes in GSH levels in the hippocampus of
the ‘‘EAE’’ group was observed, which disagree with the
results of Zheng and Bizzozero (2010) but agree with those
of Dasgupta et al. (2013). In view of these results and the
above-mentioned literature, it could be suggested that the pres-
ent relapsing-remitting EAE-induced Wistar rat model
attained the chronic stage at the time of decapitation (28th
day post immunization). Thus, the present EAE model could
be considered as a chronic-relapsing EAE model.
Treatment of EAE-induced animals with N. sativa after the
appearance of the ﬁrst clinical signs revealed non-signiﬁcant
changes in the cortical levels of MDA, GSH and NO as well
as the activity of GST in comparison to the ‘‘EAE’’ group.
However, protection of rats with N. sativa administered
2 weeks prior EAE induction and continuation of N. sativa
administration until 28th day post immunization resulted in
a signiﬁcant increase in the cortical MDA level with reference
to control and ‘‘EAE’’ rats and reversed the results of GSH
and NO recorded in both ‘‘EAE’’ and ‘‘N. sativa’’ groups.
Unluckily, this increase in the cortical MDA level could be
considered as one of the probable drawbacks of N. sativa
administration and this controversy between treated and pro-
tected groups could be due to the longer duration of N. sativa
Nigella sativa in encephalomyelitis-induced rats 193administration in the protected group. In accordance with
these results, Alhosin et al. (2010) had found that TQ could
produce ROS metabolites, which in turn trigger mitochondrial
membrane potential loss in Jurkat cells. Moreover, TQ has
been reported to exert anti-oxidant activity at lower concentra-
tion (Mansour et al., 2002), but at higher concentration, it
showed signiﬁcant pro-oxidant effects (EL-Najjar et al.,
2010; Koka et al., 2010).
Nitric oxide is a reactive molecule that is synthesized by
macrophages and microglia during inﬂammation (Hendriks
et al., 2005). It has been found that the levels of NO/ONOO
stable end products are elevated in MS patients (Giovannoni,
1998). In contrast to these studies, the data of the present
investigation revealed a signiﬁcant decrease in the cortical
NO level in the rats of the ‘‘EAE’’ group in comparison to
the control level.
It has been reported that NO has contradictory roles in cel-
lular systems such as an oxidant or sometimes a scavenger of
superoxide anion (Fadillioglu et al., 2003; Ilhan et al., 2004).
Gulati et al. (2007) reported a reversal of function of NO from
antioxidant at lower concentration, to pro-oxidant at higher
concentration.
El-Mahmoudy et al. (2002) investigated the effect of TQ on
NO production by macrophages after lipopolysaccharide stim-
ulation and found that TQ suppresses the production of NO
by macrophages. This reveals that TQ mediates its inhibitory
effect on NO production via reduction of iNOSmRNA and
protein expression. The authors suggested that this might be
important in ameliorating the inﬂammatory and autoimmune
conditions. As TQ is the main active component in N. sativa
seeds, therefore, the present signiﬁcant decrease in the cortical
NO level in the ‘‘EAE + N. sativa’’ group is in accordance
with the study of El-Mahmoudy et al. (2002).
In the hippocampus, results of both treated and protected
groups showed a signiﬁcant decrease in MDA level accompa-
nied by a signiﬁcant increase in NO level and decrease in cat-
alase activity in the case of the treated group ‘‘EAE + N.
sativa’’ only.
There is evidence that serum NO may have protective
immunomodulatory effects: NO inhibits Th1 cell proliferation,
and the expression of adhesion molecules and proinﬂamma-
tory cytokines (Taylor-Robinson et al., 1994; De Caterina
et al., 1995). Rats recovering from EAE had signiﬁcantly
increased serum NO production and this seemed to protect
them against a second episode of the disease (O’Brien et al.,
1999). Moreover, Hummel et al. (2006) described the antioxi-
dant effect of NO. A previous study of Kanner et al. (1992)
showed that NO reduced the generation of ROS, such as
hydrogen peroxide and superoxide and prevented lipid perox-
idation. Therefore, it could be suggested that the increase in
NO level in the hippocampus of the ‘‘EAE + N. sativa’’ group
may provide a protective mechanism against suspected incom-
ing relapse.
It is noticeable from the present oxidative stress analysis
that the effect of N. sativa is variable in different brain areas,
which may be due to the differential uptake of N. sativa con-
stituents. In addition, the dose and duration of N. sativa
administration must be taken into consideration to avoid its
probable pro-oxidant effect.
In conclusion, the whole N. sativa seeds could attenuate the
clinical signs, suppress inﬂammation and lead to remyelination
in EAE-induced Wistar rats. Therefore, N. sativa seeds couldbe used as a protective agent or an adjunct treatment for
EAE even when the treatment started after the appearance
of the ﬁrst clinical signs.
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